• In particular, she is interested in identifying the structure-activity relationships of these analogs. (wikipedia.org)
  • These proteins can be present in a cell as single molecules (monomers) or as a group of several chaperone molecules (oligomers). (elifesciences.org)
  • propose that BiP oligomers act as reservoirs to store BiP molecules when they aren't needed by the cell. (elifesciences.org)
  • The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. (oncotarget.com)
  • L-767,827, an inactive structural analog of the insulin mimetic, had no effect on β-cell [Ca 2+ ] i . (diabetesjournals.org)
  • Solid-phase synthesis protocols were developed for preparation of three already validated prodrugs of thapsigargin: one prodrug cleavable by human kallikrein 2, one prodrug cleavable by prostate-specific antigen, and one prodrug cleavable by prostate-specific membrane antigen. (ku.dk)
  • 2. Thapsigargin--from Thapsia L. to mipsagargin. (nih.gov)
  • 7. Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer Therapeutics. (nih.gov)
  • 13. Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours. (nih.gov)
  • 4. Targeting thapsigargin towards tumors. (nih.gov)
  • In the case of thapsigargin, selectivity for tumor-associated cells is achieved by conjugating the drug to a peptide that is only cleaved in the vicinity of tumors to release the cytotoxic drug or an analog with retained activity. (ku.dk)
  • 17. The effects of the phenylalanine 256 to valine mutation on the sensitivity of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) Ca2+ pump isoforms 1, 2, and 3 to thapsigargin and other inhibitors. (nih.gov)
  • Her interests consider cycloaddition reactions that can realise molecules and natural products for organic photovoltaics and targeted covalent inhibitors. (wikipedia.org)
  • She works on the design, synthesis, and characterization of guaianolide analog covalent inhibitors with muted reactivity to thiols. (wikipedia.org)
  • In particular, she is interested in identifying the structure-activity relationships of these analogs. (wikipedia.org)
  • Here, we report that topical application of PY-60, a small-molecule activator of the transcriptional coactivator Yes-associated protein (YAP), promotes regenerative repair of cutaneous wounds in pig and human models. (bvsalud.org)
  • Here, we employed a screening approach that included complementary arm-specific UPR reporters and medium-throughput transcriptional profiling to identify non-toxic small molecules that phenocopy the ATF6-mediated reprogramming of the ER proteostasis environment. (elifesciences.org)
  • These results show that small molecule-dependent ER reprogramming, achieved through preferential activation of the ATF6 transcriptional program, is a promising strategy to ameliorate imbalances in ER function associated with degenerative protein aggregation diseases. (elifesciences.org)
  • One approach to overcome this problem involves attempts at developing drugs based on general cytotoxins, like calicheamicin and thapsigargin, which kill cells at all phases of the cell cycle. (ku.dk)
  • used a new approach to screen over 600,000 small molecules and identified a small number that could activate ATF6-regulated genes without inducing global endoplasmic reticulum stress. (elifesciences.org)
  • In the study, these lupane-type triterpenes were evaluated for their inhibitory effect on histamine release from basophilic leukemia (RBL-2H3) cell line, a tumor analog of mast cells. (ijtpr.com)
  • The release of histamine from this mast cell was immunologically and non-immunologically stimulated by DNP 24 -BSA and thapsigargin, respectively. (ijtpr.com)
  • However, these compounds did not alter the histamine release from mast cells induced by thapsigargin. (ijtpr.com)
  • One of the small molecules tested effectively reduced the release of these proteins and prevented harmful deposits of the proteins forming in the spaces surrounding cells. (elifesciences.org)
  • Now, two groups of researchers have independently identified small molecules that specifically target ATF6. (elifesciences.org)